Agitation over the potential impact of the medications has been exacerbated by surveys showing tens of millions of respondents expressing an interest in a drug that could help them lose weight safely.
The Metropoulos investment of $410 million in a business nearly left for dead has blossomed into a company with a market capitalization of $4.45 billion.